Targeted Therapy for Sleep Disorders Helps Patients with Muscular Dystrophy

Treatments Most Effective When Matched to Symptoms, as Reported in the Journal of Neuromuscular Diseases

January 17, 2017 - Myotonic dystrophy type 1 (DM1) is the most common adult muscular dystrophy, and many patients with DM1 suffer from various sleep and respiratory disorders. In a study in the current issue of the Journal of Neuromuscular Diseases, researchers found that because there is wide range of sleep problems, treatments do not fit a “one size fits all” model. More...

January 17, 2017

Not All Europeans Receive the Same Care for Duchenne Muscular Dystrophy

Researchers Report Significant Regional and Age-Dependent Differences, in the Journal of Neuromuscular Diseases

January 3, 2017 - Duchenne muscular dystrophy (DMD), a progressive muscle disease affecting one in 3800-6300 live male births and leads to ambulatory loss, respiratory problems, cardiomyopathy, and early death of patients in their 20s or 30s. While incurable, multidisciplinary treatment can raise life expectancy into the fourth decade. However, in a survey across seven European countries, researchers found striking differences in access to appropriate care. There were significant inequities between different countries and different age groups, which would likely lead to different health outcomes. More...

January 3, 2017

Promising discovery for a non-invasive early detection of Alzheimer’s disease

December 23, 2016 - A discovery of high relevance in medical research will be published in Volume 55, number 4 of December 2016 of the prestigious “Journal of Alzheimer’s disease (JAD)”, entitled “Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer’s Disease”. This paper has been highlighted as one of the most important contribution to this field. The paper stems from a fruitful collaboration between the neuroscience laboratory from the International Center for Biomedicine (ICC) under the leadership of Dr. Ricardo Maccioni and the research teams of Drs. Andrea Slachevsky, Faculty of Medicine, University of Chile, together with Drs. Oscar Lopez and James Becker from University of Pittsburgh, School of Medicine, USA. More...

December 23, 2016

Occupational therapy may have the potential to slow down functional decline and reduce behavioral troubles in dementia patients

December 23, 2016 - Bordeaux, France – A French observational study in real life showed that dementia patients benefiting from occupational therapy sessions report relevant clinical benefits over the intervention period, according to a research study published in the Journal of Alzheimer’s Disease this month. The research suggested the influence of occupational therapy on reducing behavioral troubles, caregivers’ burden and amount of informal care over the intervention period and a stabilization over the 3-months period thereafter. More...

December 23, 2016